Glaucoma

In visual field progression results, SLT was superior to ocular drops as first-line treatment for patients with glaucoma

Uncertainty during everyday navigation tasks may adversely affect quality of life for patients with glaucoma

Research by investigators at Trinity College in Dublin, Ireland shows how the gene therapy conferred significant protection for retinal ganglion cells

Smaller surgeries, in greater numbers, await new glaucoma specialists

Femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) received approval for patients in Europe with primary open-angle glaucoma

Management of neovascular glaucoma focuses on decreasing retinal ischemia through panretinal photocoagulation and the injection of anti-VEGF agents

Metabolomics reflects the physiological state of a tissue and provides information about interactions between genetics, environment and lifestyle

Investigators assessed the XEN45 implant alone and in combination with phacoemulsification

Early results indicate that trained optometrists delivered safe and effective laser treatments

This year’s meeting will take place in Ireland’s technology and business hub

Three approaches to examination give a comprehensive overview

Three leaders in glaucoma research, retina care and refractive surgery share their expertise

Proteins common to Alzheimer disease play a significant role in glaucoma

Innovative therapies scale up to meet needs of a growing patient population

The company made its CE Mark announcement during the ESCRS Winter Meeting

According to the company, the patent further protects Iridex’s intellectual property encompassing laser systems in ophthalmology and related fields

Standalone, minimally-invasive glaucoma treatments

The partnership establishes a large-scale enrollment platform for research on MicroPulseTransscleral Laser Therapy (TLT)

Prevent Blindness will offer downloadable fact sheets, shareable social media graphics and educational videos for patients

In 2024, the waiting game will pay off for glaucoma specialists who are eager to develop fluency and implement new devices into their practices

Analysis suggested no evidence for a causal association of lifetime cannabis use and cannabis use disorder with primary open-angle glaucoma

More testing is needed to ensure accuracy across different groups

Results showed that the PAUL Glaucoma Implant is an effective glaucoma drainage device that provides effective IOP lowering, similar to that achieved with the Baerveldt Glaucoma Implant, but with lower rates of complications

The approach to lowering intraocular pressure reduces medication burden without risking graft rejection

In the years to come, Ciliatech will release more data around their novel Cilioscleral Interposition Device (CID)

The director of Frankfurt’s Bürgerhospital eye hospital shared 7 years’ data on the iStent inject®

The glaucoma specialist spoke about his ESCRS agenda–and his calendar for 2024

The diagnostics company is using AI to screen for diabetic retinopathy, glaucoma and age-related macular degeneration

As part of the meeting’s MIGS programme, Keith Barton, MD, FRCP, FRCS, FRCOphth, shared data from the iTrack™ Global Data Registry

MERCURY-3 trial data show latanoprost/netarsudil fixed-dose combination (Roclanda) demonstrated comparable IOP lowering efficacy to bimatoprost/timolol combination, in patients with primary open-angle glaucoma or ocular hypertension.